Inhibition of nonsense mediated mRNA decay by drugs that prevent hypusination of eukaryotic initiation factor 5a
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- RUTGERS THE STATE UNIV
- Publication Date
- 2017-11-09
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] The instant application claims priority under 35 U.S.C. §119(e) to U.S. Provisional Application No. 61 / 496,378, filed Jun. 13, 2012, and is also a continuation-in-part of U.S. application Ser. No. 12 / 840,270, filed Jul. 20, 2010, which claims 35 U.S.C. §119(e) priority to U.S. Provisional Application No. 61 / 271,409, filed Jul. 20, 2009, all of which are incorporated by reference in their entirety.FIELD OF THE INVENTION
[0002] The present invention relates to methods of treating nonsense-associated diseases and inhibiting nonsense-mediated mRNA decay by administering an inhibitor of NMD and a nonsense suppressor.BACKGROUND OF THE INVENTION
[0003] Nonsense-mediated decay (“NMD”) is a cellular mechanism that selectively degrades faulty messenger RNA (“mRNA”) containing an out-of-place stop (nonsense) codon. If translated, such mRNAs would produce a shortened version of the encoded protein. The NMD surveillance mechanism reduces or prevents the f...